Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention.


To investigate the relationship between CHEK2 mutation status and estrogen receptor (ER) status in unselected cases of early-onset breast cancer from Poland, we screened 4441 women diagnosed with breast cancer younger than 51 years and 7217 controls for three inherited mutations in CHEK2 (1100delC, IVS2+1G>A, del5395). ER status was compared between CHEK2… (More)
DOI: 10.1111/j.1399-0004.2008.01111.x


4 Figures and Tables

Slides referencing similar topics